Skip to main content
Log in

Monitoring Adherence to HIV Antiretroviral Therapy in Routine Clinical Practice: The Past, the Present, and the Future

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  • Artinian, N.T., Harden, J.K., Kronenberg, M.W., Vander Wal, J.S., Daher, E., & Stephens, Q. (2003). Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure. Heart Lung, 32(4), 226–233.

    Article  PubMed  Google Scholar 

  • Bangsberg, D.R., Acosta, E., Gupta, R., Guzman, D., Riley, E.D., & Harrigan, P.R. (2005). Differences in protease and non-nucleoside reverse transcriptase inhibitor adherence-resistance relationships are explained by virologic fitness. AIDS, 20(2), 223–231.

    Article  CAS  Google Scholar 

  • Bangsberg, D.R., Bronstone, A., Chesney, M.A., & Hecht, F.M. (2002). Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. Journal Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S107–S111.

    Google Scholar 

  • Bangsberg, D.R., Charlebois, E.D., Grant, R.M., Holodniy, M., Deeks, S.G., & Perry, S. (2003). High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS, 17(13), 1925–1932.

    Article  PubMed  Google Scholar 

  • Bangsberg, D.R., Hecht, F., Clague, H., Charlebois, E., Ciccarone, D., & Chesney, M. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26(5), 435–442.

    PubMed  CAS  Google Scholar 

  • Bangsberg, D.R., Hecht, F.M., Charlebois, E.D., Zolop, A.R., Holodniy, M., & Sheiner, L. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14(4), 357–366.

    Article  PubMed  CAS  Google Scholar 

  • Bangsberg, D.R., Perry, S., Charlebois, E.D., Clark, R.A., Roberston, M., & Zolopa, A.R. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15(9), 1181–1183.

    Article  PubMed  CAS  Google Scholar 

  • Bova, C.A., Fennie, K.P., Knafl, G.J., Dieckhaus, K.D., Watrous, E., & Williams, A.B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS Behavior, 9(1), 103–110.

    Article  Google Scholar 

  • de Olalla, G., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J.L., & Cayla, J.A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal Acquired Immune Deficiency Syndrome, 30(1), 105–110.

    Article  Google Scholar 

  • Gross, R., Bilker, W.B., Friedman, H.M., Coyne, J.C., & Strom, B.L. (2002). Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS, 16(13), 1835–1837.

    Article  PubMed  Google Scholar 

  • Gross, R., Zhang, Y., & Grossberg, R. (2005). Medication refill logistics and refill adherence in HIV. Pharmacoepidemiology and Drug Safety.

  • Hogg, R., Heath, K., Bangsberg, D.R., Yip, B., Press, N., & O’Shaughnessy, M.V. (2002). Intermittent use of Triple Combination Therapy is Predictive of Mortality at Baseline and after one year of follow-up AIDS. AIDS, 16, 1051–1058.

    Article  PubMed  Google Scholar 

  • Jauhar, S. (2006). The demise of the physical exam. New England Journal of Medicine, 354(6), 548–551.

    Article  PubMed  CAS  Google Scholar 

  • King, M.S., Brun, S.C., & Kempf, D.J. (2005). Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir. Journal of Infectious Diseases, 191(12), 2046–2052.

    Article  PubMed  CAS  Google Scholar 

  • Maggiolo, F., Ravasio, L., Ripamonti, D., Gregis, G., Quinzan, G., & Arici, C. (2005). Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clinical Infectious Diseases, 40(1), 158–163.

    Article  PubMed  CAS  Google Scholar 

  • Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34(8), 1115–1121.

    Article  PubMed  Google Scholar 

  • Parienti, J., Massari, V., Descamps, D., Vabret, A., Bouvet, E., & Larouzé, B. (2004). Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine or Efavirenz-Based Antiretroviral Therapy. CID, 38, 1311–1316.

    Article  CAS  Google Scholar 

  • Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., & Squier, C. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medcine, 133(1), 21–30.

    CAS  Google Scholar 

  • Ruskin, P., Van der Wende, J., Clark, C., Fenton, J., Deveau, J., & Thapar, R. (2003). Feasibility of using the Med-eMonitor System in the treatment of Schizophrenia: A pilot study. Drug Information Journal, 37(3), 283–291.

    Google Scholar 

  • Simoni, J., Kurth, A., Pearson, C., Pantalone, D., Merrill, J., & Frick, P. (2006). Self-reported measures of antiretroviral therapy adherence. Aids and Behavior.

  • Spacek, L.A., Shihab, H.M., Kamya, M.R., Mwesigire, D., Ronald, A., Mayanja, H., et al. (2006). Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clinical Infectious Diseases, 42(2), 252–259.

    Article  PubMed  Google Scholar 

  • Weiser, S.D., Guzman, D., Riley, E.D., Clark, R., & Bangsberg, D.R. (2004). Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence. HIV Clinical Trials, 5(5), 278–287.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David R. Bangsberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bangsberg, D.R. Monitoring Adherence to HIV Antiretroviral Therapy in Routine Clinical Practice: The Past, the Present, and the Future. AIDS Behav 10, 249–251 (2006). https://doi.org/10.1007/s10461-006-9121-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-006-9121-7

Keywords

Navigation